Your session is about to expire
← Back to Search
Usual Care for Liver Cancer
N/A
Waitlist Available
Led By Shivan Mehta, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients who are 18+ years old
Current diagnosis of cirrhosis or advanced fibrosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial is testing whether opt-out framing and financial incentives can encourage patients with liver cirrhosis to get regular surveillance ultrasounds, which may help diagnose hepatocellular carcinoma (HCC) earlier and improve outcomes.
Eligible Conditions
- Liver Cancer
- Liver Cirrhosis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
HCC Screening Completion
Secondary outcome measures
HCC Screening Method
Trial Design
3Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
Standard of care
Group II: Opt-out + IncentiveExperimental Treatment1 Intervention
Facilitated outreach and opt-out framing plus a financial incentive
Group III: Opt-outExperimental Treatment1 Intervention
Facilitated outreach and opt-out framing
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Usual care
2011
Completed Phase 4
~24610
Opt-out
2020
N/A
~620
Opt-out + Incentive
2020
N/A
~620
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
1,992 Previous Clinical Trials
42,874,745 Total Patients Enrolled
3 Trials studying Liver Cancer
6,165 Patients Enrolled for Liver Cancer
National Institute on Aging (NIA)NIH
1,655 Previous Clinical Trials
28,003,555 Total Patients Enrolled
Shivan Mehta, MDPrincipal InvestigatorUniversity of Pennsylvania
15 Previous Clinical Trials
77,052 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger